ARGX
argenx NV ADRNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
$802.64-1.19%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- -19.0%
- 3 months
- -7.0%
- 1 year
- +0.7%
- 52-week range
- $663.93$1,058.90
- Dividend
- No dividends on record
- Short interest
- 1.4M sharessettled Sep 30, 2026 · +3.0% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if ARGX is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
82 top institutions tracked
as of 2026-Q2 (filed 2026-09-23)
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
510 filers reported a long position in ARGX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $4.9B | 5.2M | +4.8% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $2.5B | 2.7M | -20.6% |
| Jupiter Topco LLC | $2.3B | 2.5M | — |
| Capital World Investors | $2B | 2.2M | -2.5% |
| Artisan Partners Limited Partnership | $1.4B | 1.5M | +2.8% |
| Avoro Capital Advisors LLC | $927.8M | 1M | Unchanged |
| WELLINGTON MANAGEMENT GROUP LLP | $863.3M | 930.5K | -8.9% |
| BlackRock, Inc. | $721.1M | 777.2K | -3.8% |
| RTW INVESTMENTS, LP | $658.2M | 709.4K | Unchanged |
| MORGAN STANLEY | $596.7M | 643.1K | +14.7% |
Get the Full Analysis for ARGX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.